Correlation Between Eli Lilly and Artivion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Artivion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Artivion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Artivion, you can compare the effects of market volatilities on Eli Lilly and Artivion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Artivion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Artivion.

Diversification Opportunities for Eli Lilly and Artivion

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Eli and Artivion is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Artivion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artivion and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Artivion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artivion has no effect on the direction of Eli Lilly i.e., Eli Lilly and Artivion go up and down completely randomly.

Pair Corralation between Eli Lilly and Artivion

Considering the 90-day investment horizon Eli Lilly is expected to generate 1.14 times less return on investment than Artivion. But when comparing it to its historical volatility, Eli Lilly and is 1.23 times less risky than Artivion. It trades about 0.09 of its potential returns per unit of risk. Artivion is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1,549  in Artivion on August 31, 2024 and sell it today you would earn a total of  1,403  from holding Artivion or generate 90.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  Artivion

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Artivion 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Artivion are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Artivion may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Eli Lilly and Artivion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Artivion

The main advantage of trading using opposite Eli Lilly and Artivion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Artivion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artivion will offset losses from the drop in Artivion's long position.
The idea behind Eli Lilly and and Artivion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities